TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07641504: Randomized, Placebo-Controlled, Phase 2 Clinical Trial to Evaluate LY4065967 for the Treatment of Chronic Low Back Pain

Sponsor: Eli Lilly and Company · Phase: PHASE2 · Area: CARDIOLOGY_METABOLIC · Target Enrollment: 150 pts

Competing Trials Overlap

11 Active Trials

Excess Burn Exposure

$4,980,000

Rescue Site Savings

+$3,286,800

Unlock Full NCT07641504 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07641504 Rescue Dossier →